A commercial court in Pune on Saturday refused to pass an interim injunction to stop the Serum Institute of India from using the trademark “Covishield” for its vaccine against the coronavirus, reported Live Law.
On January 4, Nanded-based pharmaceutical products manufacturer Cutis Biotech in Maharashtra had filed a civil lawsuit asking the Serum Institute of India to stop using the trademark or any other similar names for its Covid-19 vaccine as the company started using it first.
In its reply, the Serum Institute had highlighted the difference in the products of the two firms and the timeline of the applications for the trademark.
“Judge AV Rote has rejected the application which had sought a perpetual injunction against Serum Institute of India for purposes of restraining it from using the trademark Covishield or any other mark which is confusingly similar with the trademark Covishield in respect of the goods which are same, similar, dissimilar with the goods of…
